Coronary revascularization and quality of life

American Heart Journal

Volumn 148, Issue 1, 2004, Pages 5-6

  Hlatky, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; TREATMENT OUTCOME;

ANGINA, UNSTABLE; HUMANS; MYOCARDIAL REVASCULARIZATION; QUALITY OF LIFE;

EID: 3142582427     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.003     Document Type: Editorial

References (21)

1. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 344:1994;563-570
2. Bucher H.C., Hengstler P., Schindler C., et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease meta-analysis of randomised controlled trials. BMJ. 321:2000;73-77
3. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 24 randomised trials. Lancet. 361:2003;13-20
4. Anderson H.V., Cannon C.P., Stone P.H., et al. One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. J Am Coll Cardiol. 26:1995;1643-1650
5. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 338:1998;1785-1792
6. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease FRISC II prospective randomised multicentre study. Lancet. 354:1999;708-715
7. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887
8. Fox K.A.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction the British Heart Foundation RITA 3 randomised trial. Lancet. 360:2002;743-751
9. Barnett P.G., Chen S., Boden W.E., et al. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction results of a randomized trial. Circulation. 105:2002;680-684
10. Mahoney E.M., Jurkovitz C.T., Chu H., et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 288:2002;1851-1858
11. Janzon M., Levin L.A., Swahn E., et al. Cost-effectiveness of an invasive strategy in unstable coronary artery disease results from the FRISC II invasive trial. Eur Heart J. 23:2002;31-40
12. CASS Principal Investigators and Their Associates. Coronary Artery Surgery Study (CASS) a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 68:1983;951-960
13. Parisi A.F., Folland E.D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med. 326:1992;10-16
14. Cobb L.A., Thomas G.I., Dillard D.H., et al. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 260:1959;1115-1118
15. Dimond E.G., Kittle C.F., Crockett J.E. Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am J Cardiol. 5:1960;483-486
16. Stone G.W., Teirstein P.S., Rubenstein R., et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 39:2002;1581-1587
17. Wilson I.B., Cleary P.D. Linking clinical variables with health-related quality of life. JAMA. 273:1995;59-65
18. Melsop K., Boothroyd D.B., Hlatky M.A. Quality of life and and utility in patients with coronary artery disease. Am Heart J. 145:2003;36-41
19. Pocock S.J., Henderson R.A., Clayton T., Lyman G.H., Chamberlain D.A. Quality of life after coronary angioplasty or continued medical treatment for angina Three-year follow-up in the RITA-2 trial. J Am Coll Cardiol. 35:2000;907-914
20. Janzon M., Levin L.A., Swahn E. Invasive treatment in unstable coronary artery disease promotes health-related quality of life results from the FRISC II trial. Am Heart J. 148:2004;112-119
21. Diderholm E., Andrén B., Frostfeldt G., et al. Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease. Am J Med. 115:2003;606-612